121 related articles for article (PubMed ID: 401003)
1. Symptomatic volunteers in multicenter drug trials.
Covi L; Lipman RS; McNair DM; Czerlinsky T
Prog Neuropsychopharmacol; 1979; 3(5-6):521-33. PubMed ID: 401003
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
[TBL] [Abstract][Full Text] [Related]
3. A comparison of demographic variables, symptom profiles, and measurements of functioning in symptomatic volunteers and an outpatient clinical population.
Rapaport MH; Frevert T; Babior S; Zisook S; Judd LL
Psychopharmacol Bull; 1995; 31(1):111-4. PubMed ID: 7675974
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic volunteers in depression research: a closer look.
Thase ME; Last CG; Hersen M; Bellack AS; Himmelhoch JM
Psychiatry Res; 1984 Jan; 11(1):25-33. PubMed ID: 6584929
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic trial participants: where do we find them and what does it cost?
Bielski RJ; Lydiard RB
Psychopharmacol Bull; 1997; 33(1):75-8. PubMed ID: 9133754
[TBL] [Abstract][Full Text] [Related]
6. Screening procedures in volunteers and patients.
Tyrer PJ
Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):35-40. PubMed ID: 9957
[No Abstract] [Full Text] [Related]
7. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects.
Messaoudi M; Lalonde R; Violle N; Javelot H; Desor D; Nejdi A; Bisson JF; Rougeot C; Pichelin M; Cazaubiel M; Cazaubiel JM
Br J Nutr; 2011 Mar; 105(5):755-64. PubMed ID: 20974015
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with choice of psychotropic drugs used for intentional drug overdose.
Tournier M; Grolleau A; Cougnard A; Molimard M; Verdoux H
Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):86-91. PubMed ID: 18806918
[TBL] [Abstract][Full Text] [Related]
9. Merging the cognitive behavioral and psychopharmacological paradigms in comparative studies: controversies, issues, and some solutions.
Gorman JM; Barlow DH; Ray S; Shear MK; Woods S
Psychopharmacol Bull; 2001; 35(2):111-24. PubMed ID: 12397891
[TBL] [Abstract][Full Text] [Related]
10. Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.
Chakos M; Patel JK; Rosenheck R; Glick ID; Hammer MB; Tapp A; Miller A; Miller D
Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):124-34. PubMed ID: 21983496
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic drug use in nursing homes--diagnostic indications and variations between institutions.
Ruths S; Straand J; Nygaard HA
Eur J Clin Pharmacol; 2001 Sep; 57(6-7):523-8. PubMed ID: 11699620
[TBL] [Abstract][Full Text] [Related]
12. Are psychotropic medications associated with differences in baseline neurocognitive assessment scores for young athletes? A pilot study.
Yengo-Kahn AM; Solomon G
Phys Sportsmed; 2015 Jul; 43(3):227-35. PubMed ID: 26200262
[TBL] [Abstract][Full Text] [Related]
13. A survey of psychotropic drug prescriptions in an oncology population.
Derogatis LR; Feldstein M; Morrow G; Schmale A; Schmitt M; Gates C; Murawski B; Holland J; Penman D; Melisaratos N; Enelow AJ; Adler LM
Cancer; 1979 Nov; 44(5):1919-29. PubMed ID: 40688
[TBL] [Abstract][Full Text] [Related]
14. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
15. Who is portrayed in psychotropic drug advertisements?
Munce SE; Robertson EK; Sansom SN; Stewart DE
J Nerv Ment Dis; 2004 Apr; 192(4):284-8. PubMed ID: 15060402
[TBL] [Abstract][Full Text] [Related]
16. A reevaluation of the exclusion criteria used in antidepressant efficacy trials.
Posternak MA; Zimmerman M; Keitner GI; Miller IW
Am J Psychiatry; 2002 Feb; 159(2):191-200. PubMed ID: 11823258
[TBL] [Abstract][Full Text] [Related]
17. Challenges in medication clinical trials.
Rudorfer MV
Psychopharmacol Bull; 1993; 29(1):35-44. PubMed ID: 8378510
[TBL] [Abstract][Full Text] [Related]
18. Clinical methodology for testing of anxiolytic drugs.
Bourin M
Therapie; 2000; 55(1):147-53. PubMed ID: 10860018
[TBL] [Abstract][Full Text] [Related]
19. Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study.
Grohmann R; Engel RR; Geissler KH; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S27-38. PubMed ID: 15052512
[TBL] [Abstract][Full Text] [Related]
20. [Anxiolytic efficacy and tolerance of tetrabamate in anxious patients abusing alcohol. Multicenter double-blind versus placebo study].
Lôo H; Guelfi JD; Malka R; Brion S; Cottin M; Gailledreau J; Raab A; Salfati M; Sarda A; Godchau M
Encephale; 1986; 12(5):291-7. PubMed ID: 3545785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
